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AbstrAct
Objectives To explore trial site staff’s perceptions 
regarding barriers and facilitators to local recruitment.
Design Qualitative semi-structured interviews with a 
range of trial site staff from four trial sites in the UK. 
Interviews were analysed thematically to identify common 
themes across sites, barriers that could be addressed and 
facilitators that could be shared with other sites.
Participants 11 members of staff from four trial sites: 
clinical grant Co-applicant (n=1); Principal Investigators 
(n=3); Consultant Urologist (n=1); Research Nurses (n=5); 
Research Assistant (n=1).
setting Embedded within an ongoing randomised 
controlled trial (the TISU trial). TISU is a UK multicentre trial 
comparing therapeutic interventions for ureteric stones.
results Our study draws attention to the initial and 
ongoing burden of trial work that is involved throughout 
the duration of a clinical trial. In terms of building and 
sustaining a research culture, trial staff described the 
ongoing work of engagement that was required to ensure 
that clinical staff were both educated and motivated to 
help with the process of identifying and screening potential 
participants. Having adequate and sufficient organisational 
and staffing resources was highlighted as being a 
necessary prerequisite to successful recruitment both in 
terms of accessing potentially eligible patients and being 
able to maximise recruitment after patient identification. 
The nature of the research study design can also 
potentially generate challenging communicative work for 
recruiting staff which can prove particularly problematic.
conclusions Our paper adds to existing research 
highlighting the importance of the hidden and complex 
work that is involved in clinical trial recruitment. Those 
designing and supporting the operationalisation of clinical 
trials must recognise and support the mitigation of this 
‘work’. While much of the work is likely to be contextually 
sensitive at the level of local sites and for individual trials, 
some aspects are ubiquitous issues for delivery of trials 
more generally.
trial registration number ISRCTN No 92289221; Pre-
results.
IntrODuctIOn
Recruiting the desired number of partic-
ipants is crucial for all clinical research 
and remains a major challenge for those 
concerned with designing and supporting 
the operationalisation of clinical trials.1 2 
The vast majority of studies exploring issues 
around trial recruitment have focused on 
trial participants’ perspectives and experi-
ences particularly around why they do or 
do not choose to consent to participate in 
clinical trials.3–7 Increasingly, researchers 
are turning their attention to investigating 
the views of staff directly involved in trial 
recruitment, recognising that they may offer 
valuable and important insights for improving 
recruitment and other trial processes.8–10 
Focussing specifically on barriers and facil-
itators to trial recruitment, these studies 
have tended to highlight the importance of 
issues such as building a research culture, 
ensuring adequate resources and the focus 
of the research for being of significance 
in terms of their potential to facilitate trial 
recruitment.11–16 More recently, researchers 
have begun to explore and document 
the emotional impact or burden that trial 
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Research
strengths and limitations of this study
 ► The approach of nesting qualitative research within 
the context of clinical trials is considered particularly 
useful for improving the evidence base for how we 
conduct clinical trials.
 ► Compared with the vast majority of studies focussing 
on clinical trials, participants’ perspectives about why 
they do or do not choose to consent, this qualitative 
study focuses on the views and experiences of staff 
involved in the recruitment process.
 ► Our study highlights and draws attention to the initial 
and ongoing burden of trial work that is involved in 
various stages throughout the duration of a clinical 
trial—this notion and the burden and associated 
consequences it can place on trial sites has been 
somewhat buried in much of the previous literature.
 ► All the participants in our study were UK based and 
a self-selecting sample focussing on issues within 
one particular trial setting. However, we think our 
findings will be transferable to other clinical trial 
settings and contexts and offer important insights 
for those concerned with designing and supporting 
the operationalisation of clinical trials.
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involvement can have on recruiting staff, an issue perhaps 
particularly pertinent in certain trial contexts (eg, cancer 
trials; trials involving children).9 17 The few published 
studies that have attempted to explore this notion have 
drawn attention to the emotional challenges of dealing 
with issues relating to tensions between research and clin-
ical roles; accepting the concept of equipoise; concerns 
about overburdening prospective participants and 
dealing with patients’ disappointment with treatment 
allocation postrandomisation.9 10 17 18
Building on this notion of trial burden or trial ‘work’, 
in this paper we present data from a qualitative study 
conducted with trial site staff as part of an evaluation 
of recruitment processes within a UK multicentre trial 
(the TISU trial). The TISU trial is a UK multicentre trial 
comparing therapeutic interventions for ureteric stones. 
Urinary stone disease is very common with an estimated 
prevalence among the general population of 2%–3% (1.8 
million people in the UK) and is a major burden on the 
National Health Service (NHS) resulting in over 84 323 
finished consultant episodes and over 97 558 bed-days in 
England in 2011 – 2012.19 Urinary tract stones are associ-
ated with severe pain as they pass through the urinary tract 
and can have a significant impact on patients’ quality of 
life due to the detrimental effect on their ability to work 
and the potential need for hospitalisation. Between a fifth 
and a third of cases require an active intervention (stone 
removal) because of failure to pass the stone, continuing 
pain, infection or obstruction to urine drainage. The two 
standard active intervention options, used routinely in 
the NHS, are extracorporeal shockwave lithotripsy and 
ureteroscopic stone retrieval (via surgery).
As with many trials, recruitment within the TISU trial 
proved more difficult than had been anticipated at the 
outset and some sites did not meet their target expec-
tations. The variability across sites relating to aspects 
of recruitment suggested nuanced differences in the 
processes relating to recruitment and we set out to 
explore trial site staff’s perceptions regarding barriers and 
facilitators to local recruitment. For the purposes of the 
TISU trial, the aim was to identify trial-specific modifiable 
factors that could enhance the facilitators and remove the 
barriers to recruitment.
MethODs
Recruitment, sampling and consent
We adopted a pragmatic approach to address recruitment 
issues in the TISU trial by including four of eight partici-
pating UK trial sites in this qualitative study. We designed 
a sampling strategy that allowed for maximum variability 
within our sample, whereby trial sites were sampled using 
a positive and negative deviant approach, that is, ‘good’ 
and ‘could do better’ sites were identified and invited to 
participate. We applied this approach both in terms of 
considerations around the total number of participants 
recruited in each site and also in terms of number of 
participants screened compared with numbers converted 
to recruits, that is, one site screened several participants 
and randomised a small proportion of these, whereas 
others screened much smaller numbers but randomised 
a larger proportion. Within these sites, we sought to inter-
view a diverse sample including those who held a range 
of trial roles such as research assistant, research nurse, 
research data manager, study PI and those with various 
other clinical roles. Email information about the study 
was distributed by the TISU trial manager, which included 
an invitation to take part in an audio-recorded interview 
relating to issues around how easy, or difficult, it was 
perceived for sites to recruit trial participants. The study 
was approved by the North of Scotland Research Ethics 
Committee (13/NS/0002). All participants gave written 
consent before participating in a telephone interview.
Data generation
One-to-one interviews were conducted by telephone 
between January and April 2015. They were semi-struc-
tured in nature (supported by a topic guide to ensure 
coverage of key issues) and conducted in a non-judge-
mental, conversational style by one of two interviewers 
(ZCS and KG) whom participants knew were non-clinical 
and not part of the team running the trial being discussed. 
Both interviewers were female and experienced qualita-
tive/mixed methods researchers with a track record in 
methodological research in the context of clinical trials. 
One interviewer (KG) also held a previous role (6 years 
previously) as trial manager in the same clinical specialty 
(urology) but a different condition and intervention. 
Neither interviewer had a clinical background nor had 
they ever had a direct role in recruiting participants to 
clinical trials. Although this valuable prior experience 
and background helped to sensitise the study team to 
the potentially pertinent issues and areas that would be 
important to explore during interviews, KG was mindful 
not to disclose to participants her own assumptions 
and opinions in this regard to avoid influencing their 
responses.
Data analysis
Interviews were audio-recorded and transcribed verbatim. 
Our approach to analysis was systematic and interpre-
tive.20 We adopted an interpretive approach in this study, 
both in terms of our chosen data collection methods 
(in-depth interviews) and approach to analysis (inductive 
thematic analysis using the Framework Approach). For 
this piece of applied research, we found the intercon-
nected stages of the Framework approach particularly 
helpful in terms of their systematic and transparent 
nature—making the approach conducive for analysing 
data as part of a team. We familiarised ourselves with the 
whole data set and following initial familiarisation with 
transcripts, developed a thematic coding framework 
based on discussions about both a priori questions and 
issues identified as emerging from the data. Initial codes 
(text labels) from this framework were then systematically 
applied to the transcript data. Data management and 
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Table 1 Sample characteristics
Trial site Number of interviewees Job description Recruiting performance
1 5  ►Grant Co-applicant
 ►Principal Investigator (PI)
 ►Consultant Urologist
 ►2 x Research Nurses (RNa; RNb)
High screeners - low converter
2 1  ►RN Low screener-high converter
3 4  ►PI
 ►2 x RNa; RNb
 ►Research Assistant (RA)
High recruiting site
4 1  ►PI Low recruiting site
initial analytic coding was facilitated by the use of NVivo 
V.10 text software. NVivo V.10 text management software 
was used to mark specific pieces of data that were identi-
fied as corresponding to the thematic index codes. More 
generally, NVivo V.10 was also used to help organise the 
data to facilitate further analytic consideration and inter-
pretation. The primary focus during the analysis was on 
the a priori study aims. Particular attention was paid to 
the types of judgement, beliefs and attitudes (including 
concerns) that people expressed in relation to recruit-
ment processes within their particular trial site, including 
views about the barriers and facilitators affecting trial 
recruitment.
results
Sample size and characteristics
Twenty-five trial site staff were approached to secure 11 
interviews which lasted between 34 and 62 min. Table 1 
illustrates the spread of staff across the four selected trial 
sites. Staff described having a range of roles in the context 
of the TISU trial, from having been involved in protocol 
and outcome measurement development (eg, one partic-
ipant was a coapplicant on the TISU grant application) 
through to having a direct role in the day-to-day processes 
involved in screening and consenting prospective trial 
participants.
When asked to describe what they thought had worked 
well or less well within their particular site, staff were 
able to identify a range of factors which they considered 
as having played a role in either positively or negatively 
impacting on their site’s ability to function effectively and 
to access potentially eligible patients successfully and, 
where appropriate, convert these to recruited trial partic-
ipants. It was evident from within our data that some of 
these factors could, to a large extent, be supported by or 
(in the case of identified barriers) mitigated by what we 
will describe as the initial and ongoing trial site ‘work’ 
engaged in by trial staff. This ‘work’ related to issues 
around ensuring engagement and ‘buy in’ to the trial 
from a range of clinical colleagues as well as work involved 
in managing organisational complexity and management 
of specific treatment preferences (held by both potential 
participants and other clinical colleagues). These are 
discussed in detail below.
trial work to access potentially eligible patients: issues of 
engagement and planning for pragmatism
Engagement
Site staff identified the requirement to work with clinical 
colleagues (as part of routine patient care), who were not 
directly related to the trial (but who were nevertheless 
important facilitators to recruitment) as having a poten-
tially negative impact on the identification of eligible 
patients. These non-trial clinical colleagues were perceived 
as being hard to engage with about the trial (both at the 
outset of the trial and on an ongoing basis) for a variety of 
reasons. Reasons cited by trial staff included: demanding 
clinical workloads; high staff turnover (eg, junior doctors 
on rotation); along with clinicians who were perceived to 
be either not particularly interested in the specific clinical 
area that the trial was concerned with or simply not that 
interested in research in general:
…to begin with, we did have some problems and they 
(clinical staff who help to identify patients) hadn’t done lots 
of research before…So it was getting everybody to be trained 
with GCP; that took quite a bit of time … they hold up the 
study if we haven’t got all those things in place… it hasn’t 
been too bad other than keep educating the doctors …a new 
doctor will come along and then you’ve got to go through it 
all again…they only tend to be between three and 6 months 
and then you get another lot… when you’re looking at a trial 
like TISU, which is going to running for quite a long time, 
you’ve got to keep that training and that enthusiasm going. 
Site 3 RNa
…senior colleagues who are not interested in pushing it 
forward (ureteric stone research), you can’t change that…I 
think our recruitment, which would possibly triple if 
everybody was on board with it, should be, educate people 
with what they should be doing … Site 3 PI
Trial staff discussed how this could be mitigated or 
potentially resolved by initial attempts to engage with and 
motivate clinical staff and also by ongoing and creative 
attempts to maintain trial ‘visibility’:
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I’ll go down to the (department) at 9.00 when the doctors 
just walk in, just to make sure they’ve got their research 
heads on as well as their clinical heads and that they will 
ring us if there’s a patient… So it’s about making them 
think that research is a normal bit of the hospital, this is the 
norm as opposed to the exception… we went down… with 
information given to the registrars and consultants at our 
monthly meetings and there are posters on the wards. There 
is a file on every ward where they would get admitted…So 
getting those nurses engaged…… Yeah, cake usually works, 
doesn’t it? Site 1 RNa
Having a strong buy in from the site PI, particularly in 
terms of raising the profile of the study and generating 
support from other clinical colleagues was also discussed 
as having an important role in maintaining trial visibility 
and keeping external colleagues engaged:
It’s pretty much a top down process, I think, from the 
consultants and the registrars. Mr X obviously has an 
invested interest in the trial doing well and tries to make 
sure that the medical teams are aware of the trial and refers 
patients if at all possible… Site 1 RNb
He’s (PI) since gone on sabbatical and what I’ve noticed is 
that actually our recruitment has taken a bit of a turn it’s 
his trial, it’s not anyone else’s trial… I think that not having 
the PI around to kind of push things forward has made our 
recruitment take a little bit of a turn recently. it’s [PI’s] baby, 
you know, (laughter)… Site 3 RA
Planning for pragmatism
In addition to discussing the importance of engaging with 
and motivating clinical colleagues to ensure that all poten-
tially eligible patients are identified, trial staff discussed 
various other challenges relating to their attempts to 
maximise the initial recruitment potential at their partic-
ular site. Some participants clearly felt their sites were 
better placed than perhaps others for this due to organ-
isational arrangements such as, for example, having a 
large geographic catchment area (ie, having the potential 
for a large recruitment ‘net’ of eligible patients); patients 
being cared for on specific wards and therefore being 
easy to locate and patients being admitted to the site 
after a diagnosis (and therefore facilitating the stream-
lining of the initial identification process). However, all 
trial staff discussed the ongoing challenge inherent at any 
site of trying to ensure that all eligible trial participants 
were approached for potential participation in the trial. 
The work involved in this process was discussed including 
attempts to maximise existing resources in terms of 
ensuring good cross cover of staff as well as developing 
innovative and proactive recruitment strategies:
we have a lot of databases which we kind of meticulously 
keep … we kind of really plan everything out …then I’ll 
put notifications in (Research Nurse) calendar and it’s just 
having that organisation down so we don’t miss any. Site 
3 RA
there’s trials that we consider generally generic between us. So 
we cross cover as much as possible. TISU is one of those ones 
that is quite amenable really for cover, it’s not too complex, 
it’s not too difficult to get your head round … because of 
running (similar related trial) we were very familiar with 
pretty much all the aspects of it including the trial paperwork 
and the database… Site 1 RNb
As can be seen in the above quotations, there was a 
general consensus that the perceived non-complex nature 
of this particular trial (as well as previous involvement in 
similar trials) could greatly facilitate the identification of 
patients and the cross cover process—and so make the 
‘work’ easier. However, sufficient resources were recog-
nised as necessary for both of these processes to happen 
and clearly some sites were in a better position than 
others in this respect with the ‘work’ of a trial often not 
being formally recognised by host institutions for those 
with clinical roles:
we don’t have a dedicated research nurse but when (RN) is 
around it works extremely well… the downside, when (RN) 
is away on leave, we don’t have a dedicated staff do the leg 
work and get the patient across so there will be some week 
or two when we may not be able to contact patients… (if 
I could) have a dedicated research nurse capturing all the 
patients who are diagnosed …and bringing those to my 
attention so …we don’t miss a single opportunity, that type 
of thing, it would be ideal.… This research activity is not 
linked into our job plans, we do it out of our goodwill. Site 
4 PI
…for TISU I am quite reliant on doctors referring patients 
to me… for me is the biggest barrier to recruitment is not 
having the control over the patients who, or the way we can 
identify patients… I’ve had some lengthy discussions with 
Mr X about this and how we recruit patients. Site 2 RN
trial work to maximise recruitment after patient identification: 
managing organisational complexity and management of 
treatment preferences
Managing organisational complexity
In addition to identifying a range of factors which could 
impact either positively or negatively on attempts to access 
potentially eligible patients at their particular site, trial 
staff reflected on both site and trial-specific opportuni-
ties and challenges which they believed could affect the 
success or otherwise of successfully recruiting identified 
patients. Perceived site-specific organisational arrange-
ment opportunities included features such as having a 
dedicated research facility (which was regarded as facil-
itating the consent process by allowing more time for 
detailed discussions); having a dedicated trial operating 
list (which helped to reduce waiting times for the interven-
tional procedures); performing one of the interventions 
at a connected private hospital (with the perception that 
patients were attracted to this) and waiting list ‘incen-
tives’ , which resulted in trial interventions being offered 
significantly earlier than the same interventions out with 
the trial.
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The research centre I would say is definitely a benefit …the 
best way really is to bring them over …and spend time going 
through everything, and perhaps draw a few diagrams, 
explain the procedures to them. Also mop up any questions 
that they perhaps haven’t understood from the doctors. Site 
3 RNa
what has been quite nice about the trial, is that patients 
have to receive their treatment within 8 weeks of being 
randomised…from our side that’s very different to what 
would happen normally. I mean, sometimes it’s sixteen 
weeks, so I mean that’s just for the (surgical intervention). 
For the [non-surgical intervention], that’s done at a private 
hospital nearby… That is the main thing but for ethical 
reasons we try not to push that too hard as a reason for why 
people should do it. Site 3 RA
Conversely, staff at other sites described not having a 
dedicated research operating list (although discussed 
their ongoing efforts in trying to secure one) and also 
discussed potential waiting list ‘disincentives’ at their 
particular hospital, whereby there was a significant 
disparity between waiting times for the two trial interven-
tions (which they felt could work against them in terms of 
patients willingness to be randomised):
Unfortunately, in this facility, sometimes the surgical option 
is not as quick as…the lithotripsy option. You can see that 
actually influencing people’s decisions, which they can have 
the earliest. I mean we’re really encouraged by the sort of a 
surgical facility to see them within the week, we’re hoping 
that will improve things. But setting something up like a 
surgical facility, you don’t do in a week or two. We’ve been 
waiting 5 weeks now to be assured that we’ve got the theatre 
staff to cover it. Site 1 RNa
Management of treatment preferences
In addition to various site-specific organisational oppor-
tunities or challenges which could clearly impact on 
trial recruitment and generate more or less work for 
trial recruiters, it was also apparent that various non-site 
specific trial factors could have an influence and these 
seemed to require ongoing work and negotiation on the 
part of recruiting staff. For example, this particular trial 
was comparing an invasive surgical procedure (which 
required a general anaesthetic) with a much less invasive 
one (although potentially more painful and requiring 
more hospital appointments). Staff described how it was 
common for prospective participants to express a prefer-
ence for the latter procedure and described the ongoing 
communication strategies and efforts involved in trying 
to somehow find a ‘balance’ in their discussions with 
patients:
A lot of patients seem a lot keener on the lithotripsy because 
obviously it’s a much less invasive procedure… we do always 
say to them, “Well, look. If you have these…you can have 
up to three treatments … three treatments and if all three of 
those fail then you will end up having (surgery) anyway", 
but generally patients are much keener to try the less invasive 
procedure first, which is understandable. Site 3 RA
The condition this trial was addressing is a particularly 
painful, and often recurrent one and so the speed with 
which the pain could be alleviated was considered to have 
a major impact on both clinician opinions and patient 
decision-making. Furthermore, the patients approached 
for participation had often had prior experience of the 
condition and of the treatment options and so sometimes 
had formed quite rationale and personal preferences that 
were not simply based on misunderstandings:
I know there’s pros and cons to both treatments on this 
study so … if I feel the registrar has jumped in and decided 
the management plan without considering TISU… It is a 
terribly painful condition, ureteric colic with stones and I 
think the speed in with which you resolve it must have a 
major impact in both the medical staff impression on what 
to do for a patient as well as the patient’s decision-making. 
Site 1 RNa
…one of the obstacles to recruitment is, that patients do 
express a preference for one treatment or the other based on 
their own circumstances… in a way I think that that’s free 
choice…I think sometimes there’s personal reasons that some 
people would prefer not to have a general anaesthetic, would 
prefer not to have to stay in overnight… Site 2 RN
DIscussIOn
Principal findings
This study explored views and experiences of staff 
involved in recruiting to a trial investigating two methods 
for treating ureteric stones. The vast majority of studies 
exploring issues around trial recruitment have focused 
on trial participants’ perspectives and experiences partic-
ularly around why they do or do not choose to consent. 
Perhaps as a consequence of this, recruitment interven-
tions have tended to be targeted at the individual patient 
level.8 21 In comparison, relatively few studies have focused 
on the views of individuals responsible for participant 
recruitment, particularly about the broader processes 
of recruiting participants to clinical trials.8 Of those that 
have, issues such as building and supporting a research 
culture, ensuring adequate resources and the focus of 
the research have all been deemed as important in terms 
of their potential to facilitate trial recruitment.11–16 Our 
study supports these findings and also highlights and 
draws attention to the important notion of the initial and 
ongoing burden of trial work that is involved in each of 
these aspects, building on emerging recent findings from 
studies which have attempted to uncover some of the 
emotional ‘hidden challenges’ staff can face with regard 
to recruitment.9 18 In terms of building and sustaining 
a research culture, trial staff in our study described 
the initial and ongoing work of engagement that was 
required to ensure that clinical staff were both educated 
and motivated to help with the process of identifying and 
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screening potential prospective participants to the trial, 
which may have implications for all research studies run 
at such sites. Having adequate and sufficient organisa-
tional and staffing resources was highlighted as being 
a necessary prerequisite to successful recruitment both 
in terms of accessing potentially eligible patients as well 
being able to maximise recruitment after patient iden-
tification and having few or no dedicated research staff 
at a site clearly created extra work in terms of juggling 
research roles with other clinical duties and respon-
sibilities. Furthermore, our study demonstrated that 
the nature of the research study design can potentially 
generate more challenging communicative work for 
recruiting staff which can prove particularly problematic. 
For example, having trial interventions that have very 
different waiting times can make it harder for recruiters 
to convince prospective participants that there be no 
disadvantage to them in being randomised (if, as is the 
case with the TISU trial, a desirable outcome is likely to 
be fastest route to alleviation of pain). Also, comparing 
invasive interventions (requiring surgery) to less inva-
sive ones will always generate potential communicative 
work for recruiting staff presenting a trial to prospective 
participants who may tend to have a natural inclination 
to favour the less invasive procedure.
Our study findings resonate strongly with recent theo-
retical work designed with complex interventions in mind 
which has highlighted that researchers are less inclined 
to think through the various demands that trial processes 
can place on those engaged in recruitment.22 The 
Normalisation Process Theory addresses issues important 
for successful implementation and integration of health-
care interventions into routine work and suggests that 
researchers could benefit from paying more attention 
to, for example, the varied contexts of trial sites and also 
considerations around how necessary trial processes ‘fit’ 
with routine practice.
strengths and limitations
The approach of nesting qualitative research within the 
context of clinical trials is considered particularly useful 
for improving the evidence base for how we conduct 
trials. Most qualitative research within this context to date 
has considered views about different trials in different 
centres with fewer studies exploring views about the same 
trial across different settings.15 By exploring the views of 
staff working within the same trial but across different 
performing sites we were able to highlight a range of both 
generic and site-specific aspects that could impact on 
patient identification and recruitment—aspects that will 
likely be very much transferable to other trials in other 
settings and contexts.
Although our study was more concerned with improving 
understanding of complex issues relating to trial recruit-
ment rather than generalisability of results, sampling 
considerations were nevertheless important. Rather than 
approaching the sampling of trial sites opportunistically, 
we instead set out to purposively select staff for our study 
based on considerations (although somewhat subjective 
ones) relating to site performance.23
However, as is the case with many qualitative studies, there 
was an element of convenience (or ‘opportunistic’) sampling 
in that ultimately we had no control over who agreed to 
be interviewed from our initial sampling ‘framework’ and 
it is important to reflect on how this might this have influ-
enced our findings. We could only interview those staff who 
responded positively to our letters of invitation (11 out of 
25 from the 4 out of 8 selected sites) and one can specu-
late that their views may have differed from non-responders 
and those from unselected sites. In terms of data saturation, 
we were satisfied that our sample size was appropriate and 
adequate in terms of enabling us to sufficiently answer our 
research aims.24 We were also reassured that there was vari-
ation in perspectives and experiences within our sample 
from staff who held a range of roles and that our study 
supports and helpfully builds on various key findings from 
other related studies.11–16
Practice implications
Recruiting to trials is a complex and ongoing process and 
is one, for trial site staff, that starts well before the process 
of attempting to consent a prospective participant (eg, 
during a one-to-one recruitment consultation). The initial 
and ongoing trial recruitment work necessary to support 
successful recruitment is critical and should be explic-
itly recognised in terms of influencing how successful 
a site will be in accessing all potential candidates and 
randomising them. Intervention developers concerned 
with improving recruitment rates could usefully focus 
on more than just the individual patient level factors 
that might be having an impact on this process. Equally, 
trial methodologists could potentially have some control 
over or at least be mindful of the various challenges at 
trial design/set up stage, as well as considering the likely 
advantages of selecting particular sites.22 Although those 
tasked with designing trials will never be able to antici-
pate all the potential challenges that sites may face across 
the duration of their involvement in trial recruitment 
(this will likely vary both within and across different trial 
sites, although several factors are generic for all trials, for 
example, buy in from clinical colleagues not involved in 
the trial), they should be mindful that the range of prac-
tical and logistical challenges inherent in trial recruitment 
all require more or less work on the part of trial recruiters 
and so support needs to be both responsive and targeted.
By nature, some clinical interventions will be poten-
tially more (or less) attractive to prospective participants, 
but there is often a real scientific need to evaluate them 
in trials with specific comparators. Rotation of junior 
clinical staff can be frequent and some clinicians may 
be more interested than others in research in general 
and/or the clinical focus of the trial which could impact 
trial recruitment over time. All these aspects, and the 
‘work’ that is required to address any deficits, need 
regular reflection and monitoring. Previous research 
has highlighted the benefits of training for recruiting 
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staff who struggle with the concept of equipoise and 
who perhaps hold particular treatment preferences, 
which make communicating trial rationale to patients 
difficult.25 Our study suggests that this training could 
perhaps be extended to offer communication training 
for staff faced with trying to recruit to studies with partic-
ular types of study designs (eg, those comparing certain 
interventions; those that have waiting time disparities, 
etc).
cOnclusIOns
Our paper has demonstrated and highlighted the hidden 
and complex ‘work’ that is involved in clinical trial 
recruitment. This notion of trial work and the burden, 
and associated consequences, that it can place on study 
sites has been somewhat buried in much of the previous 
trial literature. Those designing and supporting the oper-
ationalisation of clinical trials must recognise and support 
the mitigation of this ‘work’. While much of the work is 
likely to be contextually sensitive at the level of local sites 
and for individual trials, some aspects are ubiquitous 
issues for delivery of trials more generally.
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